← Back
$DNLI All transactions

Denali Therapeutics Inc.

A

$ Value

$0

Shares

18,111

Price

$0

Filed

Jun 5

Insider

Name

Tessier-Lavigne Marc

Title

CIK

0001437435

Roles

Director

Transaction Details

Transaction Date

2025-06-03

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

18,111

Footnotes

Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. | Includes 6,037 unvested RSUs. | The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 1, for which the Reporting Person serves as trustee. | The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 2, for which the Reporting Person serves as trustee. | The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 3, for which the Reporting Person serves as trustee. | 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Filing Info

Accession No.

0001714899-25-000136

Form Type

4

Issuer CIK

0001714899

Tessier-Lavigne Marc's History

Date Ticker Type Value
2025-06-03 DNLI A $0
2025-06-03 DNLI A $0

Other Insiders at DNLI (90d)

No other insider activity at this issuer in the last 90 days.